First News

Major factors driving the growth of this market include growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments may restrain the growth of this market. The  overall cardiac surgery instruments market  is expected to reach $1.63 Billion by 2022 from $1.16 Billion in 2017 at a CAGR of 7.1%.  North America dominated the global cardiac surgery instruments market in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market. Followed by North America, Europe dominated the global market in 2017. The European market is mainly driven by increasing adoption...

The growth of the market is mainly driven by factors such as growing prevalence of cardiac conditions and subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments are the major factors that may restrain the growth of this market. The overall  cardiac surgery instruments market  is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017 at a CAGR of 7.1%.  Market Dynamics  + Drivers + Growing Prevalence of Cardiac Conditions and Subsequent Increase in the Number of Surgical Procedures + Rising Geriatric Population + Growing Investments, Funds, and Grants By Government Bodies Request for Free Sample Pages –  https://www.marketsandmarkets.com/requestsampleNew.asp?id=162566843 North America dominated the global cardiac surgery instruments market in 2017, with the U.S....

The cardiac surgery market is mainly driven by factors such as high incidence of cardiac diseases, growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. The global  cardiac surgery instruments market  is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%.  The market in this report is segmented on the basis of products, applications, end users, and regions. Based on product, the market is segmented into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments. The forceps segment dominated the market in 2017, and it is also projected to experience the highest growth during the forecast period. The high growth in this segment is attributed to the increase in the number of cardiac surgeries and the repeated use of forceps in most cardiac procedures. Downlo...

North America dominated the global cardiac surgery instruments market in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market. The overall  cardiac surgery instruments market  is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017 at a CAGR of 7.1%. Major Key Players of the Cardiac Surgery Instruments Market are: Key players in this market include Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Teleflex Incorporated (U.S.), Medline Industries, Inc. (U.S.), KLS Martin Group (U.S.), STILLE (Sweden), Sklar Surgical Instruments (U.S.), Symmetry Surgical Inc. (U.S.), Delacroix-Chevalier (France), Wexler Surgical (U.S.), Surgins (U.K.), Surtex Instruments Ltd. (U.K.), Cardivon Surgical Inc. (China), Rumex International Corporation (U.S.), a...

Major factors driving the growth of this market include growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments may restrain the growth of this market. North America dominated the global  cardiac surgery instruments market  in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market. Followed by North America, Europe dominated the global market in 2017. The European market is mainly driven by increasing adoption of surgical procedures in cardiology, growth in European healthcare sector, and awareness programs. However, the Asian market is slated to gr...

North America dominated the global cardiac surgery instruments market in 2017, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of cardiac diseases, rising awareness programs and increased funding for research projects are likely to drive the growth of the North American market. What is experts advice about the Market Growth? The cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017 at a CAGR of 7.1%. Major factors driving the growth of this market include growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments may restrain the growth of this market. (Source: MarketsandMarkets™) Request Sample Report from Here –  https://www.marketsandmarkets.com...